FAP overexpression increases the risk of tumour invasion, lymph node metastasis and the decreased overall survival (OS) [12,13,14,15] of many solid cancers, including mCRPCa [16], especially if the cancer exhibits neuroendocrine (NE) differentiation [17]. This evidence concerns the gene FAP and neoplasm.